Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method-Reference-Cited by-同舟云学术

Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method

Published:2017-02-01 Issue:13 Volume:8 Page:20719-20728
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhou Yang¹²,Song Ruixiang³,Ma Chong³,Zhou Lina¹,Liu Xinyu¹²,Yin Peiyuan¹,Zhang Zhensheng³,Sun Yinghao³,Xu Chuanliang³,Lu Xin¹,Xu Guowang¹

Affiliation:

1. Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China

2. University of Chinese Academy of Sciences, Beijing 100049, China

3. Department of Urology, Shanghai Changhai Hospital, Secondary Military Medical University, Shanghai 200433, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Liquid Biopsy for Diagnosis of Bladder Cancer;International Neurourology Journal;2024-06-30

2. Metabolomics for searching validated biomarkers in cancer studies: a decade in review;Expert Review of Molecular Diagnostics;2024-06-21

3. Matrix- and Surface-Assisted Laser Desorption/Ionization Mass Spectrometry Methods for Urological Cancer Biomarker Discovery—Metabolomics and Lipidomics Approaches;Metabolites;2024-03-20

4. Xenobiotic metabolites modify immune responses of the cervicovaginal epithelium: potential mechanisms underlying barrier disruption;BJOG: An International Journal of Obstetrics & Gynaecology;2023-09-13

5. Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications;Biomedicine & Pharmacotherapy;2023-09